These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37460909)

  • 21. Comparison of the course of multisystem inflammatory syndrome in children during different pandemic waves.
    Ptak K; Szymońska I; Olchawa-Czech A; Kukla K; Cisowska M; Kwinta P
    Eur J Pediatr; 2023 Apr; 182(4):1647-1656. PubMed ID: 36719477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four Cases of Multisystem Inflammatory Syndrome in Adults Associated with SARS-COV-2 Infection - An Overview of Clinical Features, Diagnosis and Treatment.
    Varadaraj G; Sangeetha B; Sandhu S; Santhiya G
    J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children.
    Folga BA; Karpenko CJ; Grygiel-Górniak B
    Med Microbiol Immunol; 2023 Feb; 212(1):3-12. PubMed ID: 36396785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 infection in children and implications for vaccination.
    Nathanielsz J; Toh ZQ; Do LAH; Mulholland K; Licciardi PV
    Pediatr Res; 2023 Apr; 93(5):1177-1187. PubMed ID: 35970935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
    LaRovere KL; Poussaint TY; Young CC; Newhams MM; Kucukak S; Irby K; Kong M; Schwartz SP; Walker TC; Bembea MM; Wellnitz K; Havlin KM; Cvijanovich NZ; Hall MW; Fitzgerald JC; Schuster JE; Hobbs CV; Halasa NB; Singh AR; Mack EH; Bradford TT; Gertz SJ; Schwarz AJ; Typpo KV; Loftis LL; Giuliano JS; Horwitz SM; Biagas KV; Clouser KN; Rowan CM; Maddux AB; Soma VL; Babbitt CJ; Aguiar CL; Kolmar AR; Heidemann SM; Harvey H; Zambrano LD; Campbell AP; Randolph AG;
    JAMA Neurol; 2023 Jan; 80(1):91-98. PubMed ID: 36342679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022.
    Cortese MM; Taylor AW; Akinbami LJ; Thames-Allen A; Yousaf AR; Campbell AP; Maloney SA; Harrington TA; Anyalechi EG; Munshi D; Kamidani S; Curtis CR; McCormick DW; Staat MA; Edwards KM; Creech CB; Museru O; Marquez P; Thompson D; Su JR; Schlaudecker EP; Broder KR
    J Infect Dis; 2023 Jul; 228(2):143-148. PubMed ID: 36821777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children.
    Lam KP; Chiñas M; Julé AM; Taylor M; Ohashi M; Benamar M; Crestani E; Son MBF; Chou J; Gebhart C; Chatila T; Newburger J; Randolph A; Gutierrez-Arcelus M; Henderson LA
    Clin Immunol; 2022 Oct; 243():109106. PubMed ID: 36049601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series.
    More K; Aiyer S; Goti A; Parikh M; Sheikh S; Patel G; Kallem V; Soni R; Kumar P
    Eur J Pediatr; 2022 May; 181(5):1883-1898. PubMed ID: 35031848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review.
    Mastrolia MV; De Cillia C; Orlandi M; Abu-Rumeileh S; Maccora I; Maniscalco V; Marrani E; Pagnini I; Simonini G
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses.
    Yonker LM; Neilan AM; Bartsch Y; Patel AB; Regan J; Arya P; Gootkind E; Park G; Hardcastle M; St John A; Appleman L; Chiu ML; Fialkowski A; De la Flor D; Lima R; Bordt EA; Yockey LJ; D'Avino P; Fischinger S; Shui JE; Lerou PH; Bonventre JV; Yu XG; Ryan ET; Bassett IV; Irimia D; Edlow AG; Alter G; Li JZ; Fasano A
    J Pediatr; 2020 Dec; 227():45-52.e5. PubMed ID: 32827525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health.
    Rafferty MS; Burrows H; Joseph JP; Leveille J; Nihtianova S; Amirian ES
    J Infect Public Health; 2021 Apr; 14(4):484-494. PubMed ID: 33743370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in COVID-19 and Multisystem Inflammatory Syndrome in Children.
    Avcu G; Arslan SY; Soylu M; Bilen NM; Bal ZS; Cicek C; Kurugol Z; Ozkinay F
    Viral Immunol; 2022 Dec; 35(10):681-689. PubMed ID: 36534467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children.
    Burns MD; Bartsch YC; Davis JP; Boribong BP; Loiselle M; Kang J; Kane AS; Edlow AG; Fasano A; Alter G; Yonker LM
    Pediatr Res; 2023 Oct; 94(4):1327-1334. PubMed ID: 37173406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
    Conway SR; Lazarski CA; Field NE; Jensen-Wachspress M; Lang H; Kankate V; Durkee-Shock J; Kinoshita H; Suslovic W; Webber K; Smith K; Cohen JI; Burbelo PD; Zhang A; Teach SJ; Ibeh T; Delaney M; DeBiasi RL; Keller MD; Bollard CM
    Front Immunol; 2021; 12():793197. PubMed ID: 35116027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe.
    Bizjak M; Emeršič N; Zajc Avramovič M; Barbone F; Ronchese F; Della Paolera S; Conversano E; Amoroso S; Vidoni M; Vesel Tajnšek T; Mlakar G; Berce V; Markelj G; Plankar Srovin T; Golli T; Osredkar D; Koren Jeverica A; Toplak N; Pokorn M; Avšič Županc T; Ihan A; Fafangel M; Taddio A; Avčin T
    Clin Exp Rheumatol; 2023 May; 41(5):1183-1191. PubMed ID: 36377567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
    Anderson EM; Diorio C; Goodwin EC; McNerney KO; Weirick ME; Gouma S; Bolton MJ; Arevalo CP; Chase J; Hicks P; Manzoni TB; Baxter AE; Andrea KP; Burudpakdee C; Lee JH; Vella LA; Henrickson SE; Harris RM; Wherry EJ; Bates P; Bassiri H; Behrens EM; Teachey DT; Hensley SE
    J Pediatric Infect Dis Soc; 2021 May; 10(5):669-673. PubMed ID: 33263756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Characteristics Associated with COVID-19 in Children with Typical Presentation and with Multisystem Inflammatory Syndrome.
    Kornitzer J; Johnson J; Yang M; Pecor KW; Cohen N; Jiang C; Ming X
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C).
    Giordano S; Failla MC; Li Cavoli MG; Romano D; Vanella V; Caruso C; Chillura I; Maggio MC
    Am J Case Rep; 2021 Oct; 22():e931570. PubMed ID: 34635631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination.
    Wangu Z; Swartz H; Doherty M
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
    Torres JP; Izquierdo G; Acuña M; Pavez D; Reyes F; Fritis A; González R; Rivacoba C; Contardo V; Tapia LI
    Int J Infect Dis; 2020 Nov; 100():75-81. PubMed ID: 32861823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.